trending Market Intelligence /marketintelligence/en/news-insights/trending/CFr-CTUU9a9UdTPIZcuifQ2 content esgSubNav
In This List

Nektar Therapeutics exec joins AntriaBio board

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Nektar Therapeutics exec joins AntriaBio board

AntriaBio Inc. added Gil Labrucherie to its board.

Labrucherie is senior vice president and CFO of Nektar Therapeutics.